Afya (NASDAQ:AFYA) Stock Rating Upgraded by Wall Street Zen

Key Points

• Afya's stock rating was upgraded from "buy" to a "strong-buy" by Wall Street Zen, reflecting increased investor confidence.
• Analysts at Morgan Stanley set a $17.50 target price, while JPMorgan Chase increased their target from $23.50 to $24.50, indicating positive outlooks for the company.
• Institutional investors and hedge funds hold approximately 88.02% of Afya's stock, showing strong institutional backing.

Afya (NASDAQ:AFYA - Get Free Report) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a research note issued on Saturday.

Several other analysts also recently weighed in on the company. Morgan Stanley set a $17.50 target price on Afya and gave the company an "overweight" rating in a research note on Wednesday, August 6th. UBS Group upgraded Afya from a "neutral" rating to a "buy" rating and decreased their target price for the company from $19.50 to $19.00 in a research note on Monday, September 8th. Citigroup upgraded Afya from a "sell" rating to a "neutral" rating and decreased their target price for the company from $16.00 to $14.00 in a research note on Tuesday, July 29th. Zacks Research upgraded Afya to a "hold" rating in a research note on Friday, August 8th. Finally, JPMorgan Chase & Co. upgraded Afya from a "neutral" rating to an "overweight" rating and increased their target price for the company from $23.50 to $24.50 in a research note on Monday, September 8th. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Afya has a consensus rating of "Hold" and an average target price of $18.20.

Afya Price Performance

Shares of NASDAQ:AFYA opened at $15.60 on Friday. The business has a 50 day moving average price of $15.06 and a 200 day moving average price of $16.98. Afya has a twelve month low of $13.47 and a twelve month high of $19.90. The company has a market cap of $1.46 billion, a price-to-earnings ratio of 11.82, a PEG ratio of 0.54 and a beta of 0.56. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.22.

Hedge Funds Weigh In On Afya

Several large investors have recently added to or reduced their stakes in the company. Wellington Management Group LLP acquired a new position in shares of Afya in the 4th quarter worth approximately $829,000. BNP Paribas Financial Markets acquired a new position in shares of Afya in the 4th quarter worth approximately $228,000. Cerity Partners LLC acquired a new position in shares of Afya in the 1st quarter worth approximately $476,000. Yorktown Management & Research Co Inc acquired a new position in shares of Afya in the 1st quarter worth approximately $321,000. Finally, Two Sigma Advisers LP raised its holdings in shares of Afya by 27.2% in the 4th quarter. Two Sigma Advisers LP now owns 78,600 shares of the company's stock worth $1,248,000 after buying an additional 16,800 shares in the last quarter. Institutional investors and hedge funds own 88.02% of the company's stock.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.